Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. Income Statement 2010–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenue | 41,000 | 20,000 | 426,000 | -68,000 | 4.4M | 8.2M | 5.8M | 10.3M | 10.7M | 3.2M | 24.3M | 21.0M |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | ||||||||||||
| Operating Income | -94.5M | -103.2M | -95.9M | -87.7M | -96.9M | -54.8M | -21.5M | -42.8M | -52.0M | -11.1M | -11.7M | -23.6M |
| EBITDA | — | — | — | -87.9M | -96.4M | -54.4M | -21.1M | — | — | — | -11.3M | -22.5M |
| Net Income | -88.1M | -95.1M | -88.4M | -84.7M | -97.1M | -49.0M | -20.5M | -39.2M | -46.4M | -11.1M | -3.8M | -34.8M |
| Per Share Data | ||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 88M | 71M | 53M | 47M | 41M | 26M | 15M | 9M | 1M | 66M | 48M | 46M |
Altimmune, Inc. Income Statement — FAQ
Altimmune, Inc. (ALT) income statement over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's income statement history?
The chart and table above show Altimmune, Inc.'s income statement by year and by quarter, including the growth rate.